[Federal Register Volume 78, Number 120 (Friday, June 21, 2013)]
[Notices]
[Pages 37551-37553]
[FR Doc No: 2013-14889]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0001]

Request for Nominations for Voting and/or Nonvoting Consumer
Representatives on Public Advisory Committees or Panels and Request for
Notification From Consumer Organizations Interested in Participating in
the Selection Process for Nominations for Voting and/or Nonvoting
Consumer Representatives on Public Advisory Committees or Panels

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any
consumer organizations interested in participating in the selection of
voting and/or nonvoting consumer representatives to serve on its
advisory committees or panels notify FDA in writing. FDA is also
requesting nominations for voting and/or nonvoting consumer
representatives to serve on advisory committees and/or panels for which
vacancies currently exist or are expected to occur in the near future.
Nominees recommended to serve as a voting or nonvoting consumer
representative may either be self-nominated or may be nominated by a
consumer organization. Nominations will be accepted for current
vacancies and for those that will or may occur through December 2013.

DATES: Any consumer organization interested in participating in the
selection of an appropriate voting or nonvoting member to represent
consumer interests on an FDA advisory committee or panel may send a
letter or email stating that interest to FDA (see ADDRESSES) by July
22, 2013, for vacancies listed in this notice. Concurrently, nomination
materials for prospective candidates should be sent to FDA (see
ADDRESSES) by July 22, 2013.

ADDRESSES: All statements of interest from consumer organizations
interested in participating in the selection process and consumer
representative nominations should be sent electronically to
<EMAIL_ADDRESS>by mail to Advisory Committee Oversight and Management
Staff, 10903 New Hampshire Ave., WO32 Rm. 5129, Silver Spring Maryland
20993-0002, or by fax to<PHONE_NUMBER>. Information about becoming a
member of an FDA advisory committee can be obtained by

visiting FDA's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Dornette Spell-LeSane, Advisory
Committee Oversight and Management Staff, Food and Drug Administration,
White Oak Bldg. 32, 10903 New Hampshire Ave., Rm. 5129, Silver Spring,
MD 20993-0002,<PHONE_NUMBER>, email<EMAIL_ADDRESS>    For questions relating to specific advisory committees or panels,
contact the following persons listed in table 1:

                       Table 1--Committee Contact
------------------------------------------------------------------------
                Contact person                      Committee/panel
------------------------------------------------------------------------
Stephanie Begansky, Center for Drug            Anesthetic and Analgesic
 Evaluation and Research, Food and Drug         Drugs.
 Administration, White Oak Bldg 31, 10903 New
 Hampshire Ave., rm. 2408, Silver Spring, MD
 20993-0002,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>,
 email<EMAIL_ADDRESS>Diane Goyette, Center for Drug Evaluation and  Anti-Infective Drugs.
 Research, Food and Drug Administration,
 White Oak Bldg 31, 10903 New Hampshire Ave.,
 rm. 2408, Silver Spring, MD 20993-0002, 301-
 796-9014, FAX:<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>Nicole Vesely, Center for Drug Evaluation and  Cardiovascular & Renal
 Research, Food and Drug Administration,        Drugs.
 White Oak Bldg 31, 10903 New Hampshire Ave.,
 rm. 2408, Silver Spring, MD 20993-0002, 301-
 796-0063, FAX:<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>Cindy Hong, Center for Drug Evaluation and     Pulmonary Allergy Drugs.
 Research, Food and Drug Administration,
 White Oak Bldg 31, 10903 New Hampshire Ave.,
 rm. 2528, Silver Spring, MD 20993-0002, 301-
 796-0889, FAX:<PHONE_NUMBER>, email:
<EMAIL_ADDRESS>Jamie Waterhouse, Center for Devices and       Circulatory System
 Radiological Devices, Food and Drug            Devices.
 Administration, White Oak Bldg 66, 10903 New
 Hampshire Ave., rm. 1611, Silver Spring, MD
 20993-0002,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>,
 email<EMAIL_ADDRESS>------------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting
and/or nonvoting consumer representatives for the vacancies listed in
table 2:

      Table 2--Committee Description, Type of Consumer Representative Vacancy, and Approximate Time Needed
----------------------------------------------------------------------------------------------------------------
  Committee/panel/areas of expertise
                needed                     Current and upcoming vacancies          Approximate date needed
----------------------------------------------------------------------------------------------------------------
Anesthetic and Analgesic Drugs--        1--Voting..........................  Immediately.
 Knowledgeable in the fields of
 anesthesiology, analgesics (such as
 abuse deterrent opioids, novel
 analgesics, and issues related to
 opioid abuse) epidemiology or
 statistics, and related specialties.
Anti-Infective Drugs--Knowledgeable in  1--Voting..........................  December 1, 2013.
 the fields of infectious disease,
 internal medicine, microbiology,
 pediatrics, epidemiology or
 statistics, and related specialties.
Cardiovascular and Renal Drugs--        1--Voting..........................  July 1, 2013.
 Knowledgeable in the fields of
 cardiology, hypertension, arrhythmia,
 angina, congestive heart failure,
 diuresis, and biostatistics.
Pulmonary Allergy Drugs--Knowledgeable  1--Voting..........................  June 1, 2013.
 in the fields of pulmonary medicine,
 allergy, clinical immunology, and
 epidemiology or statistics.
Circulatory System Devices--            1 Non-Voting.......................  July 1, 2013.
 Knowledgeable in the safety and
 effectiveness of marked and
 investigational devices for use in
 the circulatory and vascular systems.
----------------------------------------------------------------------------------------------------------------

I. Functions

A. Anesthetic and Analgesic Drug Products

    The committee reviews and evaluates available data concerning the
safety and effectiveness of marketed and investigational human drug
products for use in anesthesiology and surgery and makes appropriate
recommendations to the Commissioner of Food and Drugs.

B. Anti-Infective Drugs

    The committee reviews and evaluates available data concerning the
safety and effectiveness of marketed and investigational human drug
products for use in the treatment of infectious diseases and disorders
and makes appropriate recommendations to the Commissioner of Food and
Drugs.

C. Cardiovascular and Renal Drugs

    The committee reviews and evaluates available data concerning the
safety and effectiveness of marketed and investigational human drug
products for use in the treatment of cardiovascular and renal disorders
and makes appropriate recommendations to the Commissioner of Food and
Drugs.

D. Pulmonary-Allergy Drugs

    The committee reviews and evaluates available data concerning the
safety and effectiveness of marketed and investigational human drug
products for use in the treatment of pulmonary disease and diseases
with allergic and/or immunologic mechanisms and makes appropriate
recommendations to the Commissioner of Food and Drugs.

E. Certain Panels of the Medical Devices Advisory Committee

    The committee reviews and evaluates data on the safety and
effectiveness of marketed and investigational devices and makes
recommendations for their regulation. With the exception of the Medical
Devices Dispute Resolution Panel, each panel, according to its
specialty area: Advises on the classification or reclassification of
devices into one of three regulatory categories; advises on any
possible risks to health associated with the use of devices; advises on
formulation of product development protocols; reviews premarket
approval applications for medical devices; reviews guidelines and
guidance documents; recommends exemption of certain devices from the
application of portions of the Federal Food, Drug, and Cosmetic Act;
advises

on the necessity to ban a device; and responds to requests from the
Agency to review and make recommendations on specific issues or
problems concerning the safety and effectiveness of devices. With the
exception of the Medical Devices Dispute Resolution Panel, each panel,
according to its specialty area, may also make appropriate
recommendations to the Commissioner of Food and Drugs on issues
relating to the design of clinical studies regarding the safety and
effectiveness of marketed and investigational devices.

II. Criteria for Members

    Persons nominated for membership as consumer representatives on the
committees or panels should meet the following criteria: (1)
Demonstrate ties to consumer and community-based organizations, (2) be
able to analyze technical data, (3) understand research design, (4)
discuss benefits and risks, and (5) evaluate the safety and efficacy of
products under review. The consumer representative should be able to
represent the consumer perspective on issues and actions before the
advisory committee; serve as a liaison between the committee and
interested consumers, associations, coalitions, and consumer
organizations; and facilitate dialogue with the advisory committee on
scientific issues that affect consumers.

III. Selection Procedures

    Selection of members representing consumer interests is conducted
through procedures that include the use of organizations representing
the public interest and public advocacy groups. These organizations
recommend nominees for the Agency's selection. Representatives from the
consumer health branches of Federal, State, and local governments also
may participate in the selection process. Any consumer organization
interested in participating in the selection of an appropriate voting
or nonvoting member to represent consumer interests should send a
letter stating that interest to FDA (see ADDRESSES) within 30 days of
publication of this document.
    Within the subsequent 30 days, FDA will compile a list of consumer
organizations that will participate in the selection process and will
forward to each such organization a ballot listing at least two
qualified nominees selected by the Agency based on the nominations
received, together with each nominee's current curriculum vitae or
resume. Ballots are to be filled out and returned to FDA within 30
days. The nominee receiving the highest number of votes ordinarily will
be selected to serve as the member representing consumer interests for
that particular advisory committee or panel.

IV. Nomination Procedures

    Any interested person or organization may nominate one or more
qualified persons to represent consumer interests on the Agency's
advisory committees or panels. Self-nominations are also accepted.
Potential candidates will be required to provide detailed information
concerning such matters as financial holdings, employment, and research
grants and/or contracts to permit evaluation of possible sources of
conflicts of interest.
    All nominations should include: A cover letter; a curriculum vitae
or resume that includes the nominee's office address, telephone number,
and email address; and a list of consumer or community-based
organizations for which the candidate can demonstrate active
participation.
    Nominations also should specify the advisory committee(s) or
panel(s) for which the nominee is recommended. In addition, nominations
should include confirmation that the nominee is aware of the nomination
and is willing to serve as a member of the advisory committee or panel
if selected.
    The term of office is up to 4 years. FDA will review all
nominations received within the specified timeframes and prepare a
ballot containing the names of qualified nominees. Names not selected
will remain on a list of eligible nominees and be reviewed periodically
by FDA to determine continued interest. Upon selecting qualified
nominees for the ballot, FDA will provide those consumer organizations
that are participating in the selection process with the opportunity to
vote on the listed nominees. Only organizations vote in the selection
process. Persons who nominate themselves to serve as voting or
nonvoting consumer representatives will not participate in the
selection process.
    FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and therefore, encourages nominations of
appropriately qualified candidates from these groups.

    Dated: June 17, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2013-14889 Filed 6-20-13; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register: May 8, 2009 (Volume 74, Number 88)]
[Notices]
[Page 21679]
[DOCID:fr08my09-69]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13401-000]

Hydro Energy Technologies, LLC; Notice of Preliminary Permit
Application Accepted for Filing and Soliciting Comments, Motions To
Intervene, and Competing Applications

May 1, 2009.
    On March 19, 2009, Hydro Energy Technologies, LLC filed an
application, pursuant to section 4(f) of the Federal Power Act,
proposing to study the feasibility of the Southerly Waste Water
Treatment Plant Hydroelectric Project, to be located on Cuyahoga River,
in Cuyahoga County, Ohio.
    The proposed Southerly Waste Water Treatment Plant Hydroelectric
Project would be located at the existing Southerly Waste Water
Treatment Plant outfall and box culvert owned by the Northeast Ohio
Regional Sewer District.
    The proposed project would consist of: (1) One or more turbine/
generators with total installed capacity of 250 megawatts to be
attached directly to the treatment plant's outfall; (2) a new 20-foot-
long transmission line; and (3) appurtenant facilities. The Southerly
Waste Water Treatment Plant Project would have an estimated average
annual generation of 1,166 megawatts-hours, which would be sold to a
local utility.
    Applicant Contact: Mr. Anthony J. Marra Jr., President, Hydro
Energy Technologies, LLC, 31300 Solon Rd. Suite 12, Solon, OH 44139,
(440) 498-1000.
    FERC Contact: John Ramer,<PHONE_NUMBER>.
    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Comments, motions to intervene, notices of intent, and competing
applications may be filed electronically via the Internet. See 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link. If unable to be filed electronically,
documents may be paper-filed. To paper-file, an original and eight
copies should be mailed to: Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street, NE, Washington, DC 20426. For
more information on how to submit these types of filings please go to
the Commission's Web site located at  http://www.ferc.gov/filing-
comments.asp.
    More information about this project can be viewed or printed on the
``eLibrary'' link of Commission's Web site at http://www.ferc.gov/docs-
filing/elibrary.asp. Enter the docket number (P-13401) in the docket
number field to access the document. For assistance, call toll-free 1-
866-208-3372.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-10698 Filed 5-7-09; 8:45 am]


123456789 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 A B C D E F G H I prepared 12/ 23/ 02 by comprehensive. econ. table. ssc dc Provided to Elena Besedin at Abt with this note:

I'm attaching a workbook that reports our regional estimates of foregone commerical and recreational yield for Northern California and Northern Atlantic We will provide a detailed report of our methods in due course. For now, here's a brief synopsis of what you're seeing.

The basic modeling approach for deriving foregone yield from I& E is the same that we've used in previous case studies. We have introduced a few relatively minor changes to the procedure based on public comments and other shortcomings in the procedure that we identified ourselves. The most significant of the changes are a ( 1) a correction of the algorithm that calculates foregone production and ( 2) relaxing the assumption that all impinged individuals were age 1. Now we are assuming that the ages of impinged fish are 1 and greater, and follow an age distribution that is implied by the associated survival rates. These methods have not yet been applied to our previous case studies. They have been applied to our new case studies, which include Humboldt, Potrero, Morro Bay, Moss Landing, and Diablo Canyon ( N. California) and Millstone ( N. Atlantic)

The summary table in Rec. Losses. Regional. Extrapolation. Stratus. xls presents extrapolations on a regional basis separately for Northern Califonia and Northern Atlantic. 12 3 4 56 7 8 9 10 A B C Definitions of fields presented in sheet " econ. extrap. tidy"

Field Contents sum. com. loss. lb. model. facs Total Annual Foregone Commercial Yield ( lbs) among Model Facilities ( modeled estimate)

regional. com. landings. empirical. lbs Regional Total Annual Commercial Yield ( lbs) as Reported by NMFS ( empirical data)

regional. com. landings. lbs. extrap Estimated Regional Total Annual Foregone Commercial Yield ( lbs) Extrapolation sum. rec. loss. lb. model. facs Total Annual Foregone Recreational Yield ( lbs) among Model Facilities ( modeled estimate)

regional. rec. landings. empirical. lbs Regional Total Annual Recreational Yield ( lbs) as Reported by NMFS ( empirical data)

regional. rec. landings. lbs. extrap Estimated Regional Total Annual Foregone Recreational Yield ( lbs) Extrapolation rec. forgone. catch. n Estimated Regional Total Annual Foregone Recreational Catch ( individual fish) Extrapolation 123456789 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 A B C D E F G H I J K L M region species rec. forgone. c atch. n Group Sum of forgone catch 5 year Average Landing % Losses Species as % group n. atlantic atlantic. cod 380.3 Bottomfish 380.3 1,495,006 0.0254 16.86%

n. atlantic bluefish 79.7 Bottomfish 79.7 3,027,643 0.0026 34.14%

n. atlantic butterfish 0.4 Bottomfish 0.4 0.00%

n. atlantic cunner 14,362.5 Bottomfish 14,362.5 271,297 5.2940 3.06%

n. atlantic pollock 14.7 Bottomfish 14.7 685,841 0.0021 7.73%

n. atlantic red. hake 0.2 Bottomfish 0.2 4,778 0.05%

n. atlantic scup 254.0 Bottomfish 254.0 3,822,907 0.0066 43.10%

n. atlantic searobin 36.6 Bottomfish 36.6 463,711 0.0079 5.23%

n. atlantic tautog 5,189.2 Bottomfish 5,189.2 466,185 1.1131 5.26%

n. atlantic white. perch 217.5 Bottomfish 217.5 93,039 0.2338 1.05%

Bottomfish 20,535.1 8,869,064 0.2315 n. atlantic windowpane 0.0 Flatfish 0.0 n. atlantic winter. flounder 91,995.0 Flatfish 91,995.0 410,154 22.4294 Flatfish 91,995.0 2,525,530 3.6426 n. atlantic rainbow. smelt 7.0 Other 7.0 n. atlantic atlantic. herring 0.1 Other 0.1 n. atlantic atlantic. menhaden 9.2 Other 9.2 n. atlantic american. plaice 0.0 Other 0.0 n. atlantic blueback. herring 0.0 Other 0.0 n. atlantic little. skate 0.0 Other 0.0 Other 16.4 1,207,269 0.0014 n. atlantic striped. bass 3.9 Small Game 3.9 8,893,350 0.0000 n. atlantic mackerel. atlantic 6.6 Small Game 6.6 3,646,838 0.0002 n. atlantic weakfish 94.7 Small Game 94.7 6,874 1.3781 Small Game 105.2 15,678,352 0.0007 n. atlantic all 112,651.7 No taget 112,651.7 28,280,214 0.3983 use this as quick estimate for non seeking species group Stuart Smith 1/ 2/ 03 Fields: region, species, rec. forgone. catch. n are provided by Stratus.

' Group' grouping the species into four groups: bottomfish, flatfish,

small game, big game.

' Sum of forgone catch' is equal to ' rec. forgone. catch. n' in the case of individual species and equal to the sum of ' rec. forgone. catch. n' for species included in the group in the case of species group.

' 5 year Average Landing' is the calculated historic average landing by species/ species group over the period 1997 2001.

'% losses' is the ' Sum of forgone catch' divided by ' 5 year Average Landing' and multiplied by 100.


[Federal Register: March 22, 2006 (Volume 71, Number 55)]
[Rules and Regulations]
[Page 14383-14386]
[DOCID:fr22mr06-11]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R05-OAR-2006-0124, FRL-8040-6]

Approval and Promulgation of Air Quality Implementation Plans;
Indiana

AGENCY: Environmental Protection Agency (EPA).

ACTION: Direct final rule.

-----------------------------------------------------------------------

SUMMARY: The EPA is approving a request from the Indiana Department of
Environmental Management (IDEM) to revise the Indiana State
Implementation Plan (SIP). The revision consists of the repeal of 326
IAC 6-1, and its replacement by new articles 326 IAC 6.5 and 326 IAC
6.8. 326 IAC 6.5 contains particulate matter emission limitations for
sources in all counties in Indiana, with the exception of Lake County.
Sources located in Lake County are addressed in 326 IAC 6.8. The
revision does not change any control requirements or any other
provisions in 326 IAC 6-1.

DATES: This rule is effective on May 22, 2006, unless EPA receives
adverse written comments by April 21, 2006. If EPA receives adverse
comments, EPA will publish a timely withdrawal of the rule in the
Federal Register and inform the public that the rule will not take
effect.

ADDRESSES: Submit comments, identified by Regional Material in EDocket
(RME) ID No. EPA-R05-OAR-2006-0124, by one of the following methods:
    Federal eRulemaking Portal: http://www.regulations.gov. Follow the

on-line instructions for submitting comments.
    Agency Web site: http://docket.epa.gov/rmepub/. Regional RME, EPA's

electronic public docket and comments system, is EPA's preferred method
for receiving comments. Once in the system, select ``quick search,''
then key in the appropriate RME Docket identification number. Follow
the on-line instructions for submitting comments.
    E-mail<EMAIL_ADDRESS>    Fax:<PHONE_NUMBER>.
    Mail: You may send written comments to:
    John M. Mooney, Chief, Criteria Pollutant Section, (AR-18J), U.S.

Environmental Protection Agency, 77 West Jackson Boulevard, Chicago,
Illinois 60604.
    Hand delivery: Deliver your comments to: John M. Mooney, Chief,
Criteria Pollutant Section, (AR-18J), U.S. Environmental Protection
Agency, Region 5, 77 West Jackson Boulevard, 18th floor, Chicago,
Illinois 60604. Such deliveries are only accepted during the Regional
Office's normal hours of operation. The Regional Office's official
hours of business are Monday through Friday, 8:30 a.m. to 4:30 p.m.
excluding Federal holidays.
    Instructions: Direct your comments to RME ID No. EPA-R05-OAR-2006-
0124. EPA's policy is that all comments received will be included in
the public docket without change, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through RME, regulations.gov,
or e-mail. The EPA RME Web site and the federal regulations.gov Web
site are ``anonymous access'' systems, which means EPA will not know
your identity or contact information unless you provide it in the body
of your comment. If you send an e-mail comment directly to EPA without
going through RME or regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses. For additional instructions on submitting
comments, go to Section I of the SUPPLEMENTARY INFORMATION section of
the related proposed rule which is published in the Proposed Rules
section of this Federal Register.
    Docket: All documents in the electronic docket are listed in the
RME index at http://docket.epa.gov/rmepub/. Although listed in the

index, some information is not publicly available, i.e., CBI or other
information whose disclosure is restricted by statute. Publicly
available docket materials are available either electronically in RME
or in hard copy at Environmental Protection Agency, Region 5, Air and
Radiation Division, 77 West Jackson Boulevard, Chicago, Illinois 60604.
We recommend that you telephone Jonathan Nichols, Life Scientist, at
(312) 353-7942 before visiting the Region 5 office. This Facility is
open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding
legal holidays.

FOR FURTHER INFORMATION CONTACT: Jonathan Nichols, Life Scientist,
Criteria Pollutant Section, Air Programs Branch (AR-18J), U.S.
Environmental Protection Agency, Region 5, 77 West Jackson Boulevard,
Chicago, Illinois 60604,<PHONE_NUMBER><EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Throughout this document whenever ``we,''
``us,'' or ``our'' is used, we mean EPA. This supplementary information
section is arranged as follows:

I. General Information
    A. How can I get copies of this document and other related
information?
    B. How and to whom do I submit comments?
II. Background
III. What are the revisions that the State requests be incorporated
into the SIP?
IV. What action is EPA taking today?
V. Statutory and Executive Order Reviews

I. General Information

A. How can I get copies of this document and other related information?

    1. The Regional Office has established an electronic public
rulemaking file available for inspection at RME under ID No. EPA-R05-
OAR-2006-0124, and a hard copy file which is available for inspection
at the Regional Office. The official public file consists of the
documents specifically referenced in this action, any public comments
received, and other information related to this action. Although a part
of the official docket, the public rulemaking file does not include CBI
or other information whose disclosure is restricted by statute. The
official public rulemaking file is the collection of materials that is
available for public viewing at the Air Programs Branch, Air and
Radiation Division, EPA Region 5, 77 West Jackson Boulevard, Chicago,
Illinois 60604. EPA requests that, if at all possible, you contact the
person listed in the FOR FURTHER INFORMATION CONTACT section to
schedule your inspection. The Regional Office's official hours of
business are Monday through Friday, 8:30 a.m. to 4:30 p.m. excluding
Federal holidays.
    2. Electronic Access. You may access this Federal Register document
electronically through the regulations.gov Web site located at http://www.regulations.gov
 where you can find, review, and submit comments on

Federal rules that have been published in the Federal Register, the
Government's legal newspaper, and that are open for comment.
    For public commenters, it is important to note that EPA's policy is
that public comments, whether submitted electronically or in paper,
will be made available for public viewing at the EPA Regional Office,
as EPA receives them and without change, unless the comment contains
copyrighted material, CBI, or other information whose disclosure is
restricted by statute. When EPA identifies a comment containing
copyrighted material, EPA will provide a reference to that material in
the version of the comment that is placed in the official public
rulemaking file. The entire printed comment, including the copyrighted
material, will be available at the Regional Office for public
inspection.

B. How and to whom do I submit comments?

    You may submit comments electronically, by mail, or through hand
delivery/courier. To ensure proper receipt by EPA, identify the
appropriate rulemaking identification number by including the text
``Public comment on proposed rulemaking Region 5 Air Docket EPA-R05-
OAR-2006-0124'' in the subject line on the first page of your comment.
Please ensure that your comments are submitted within the specified
comment period. Comments received after the close of the comment period
will be marked ``late.'' EPA is not required to consider these late
comments.
    For detailed instructions on submitting public comments and on what
to consider as you prepare your comments see the ADDRESSES section and
the section I General Information of the SUPPLEMENTARY INFORMATION
section of the related proposed rule which is published in the Proposed
Rules section of this Federal Register.

II. Background

A. When did the State submit the requested rule revisions to EPA?

    IDEM submitted the requested rule revisions related to particulate
matter emissions limitations on September 1, 2005.

B. Did Indiana hold public hearings for each of these rule revisions?

    IDEM held public hearings for the rule revisions that were
submitted on

January 5, 2005, February 2, 2005, and May 4, 2005.

C. Did IDEM receive any adverse comments to these changes?

    IDEM did not receive any comments concerning 326 IAC 6-1 (regarding
repealing the rule), or 326 IAC 6.5 and 326 IAC 6.8 (regarding the new
articles).

III. What are the revisions that the State requests be incorporated
into the SIP?

    The State has requested the following revisions: the repeal of 326
IAC 6-1; the addition of 326 IAC 6.5, Particulate Matter Limitations
for each county with the exception of Lake County; and the addition of
326 IAC 6.8, Particulate Matter Limitations for Lake County. This
revision renumbers and simplifies the organizational structure of the
rule. The revision does not change any control requirements or any
other provisions in 326 IAC 6-1. The revisions are described in more
detail below:

Particulate Matter Organizational Changes

    IDEM has made a few revisions related to the particulate matter
rule. These are: repealing 326 IAC 6-1; adding particulate matter
limitations for each county, with the exception of Lake County at 326
IAC 6.5; and adding particulate matter emissions limitations for Lake
County at 326 IAC 6.8. IDEM has done this in order to streamline future
rule amendment processes by having a separate section for each company.
This rule eliminates the submittal of hundreds of pages of paper for
one emission limit amendment.

IV. What action is EPA taking today?

    We are approving revisions to the Indiana SIP in one area: to
repeal 326 IAC 6-1, and to replace it with 326 IAC 6.5 ``Particulate
Matter Limitations for all counties with the exception of Lake
County,'' and 326 IAC 6.8 ``Particulate Matter Limitations for Lake
County.''
    We are publishing this action without prior proposal because we
view this as a noncontroversial amendment and anticipate no adverse
comments. However, in the proposed rules section of this Federal
Register publication, we are publishing a separate document that will
serve as the proposal to approve the state plan if relevant adverse
written comments are filed. This rule will be effective May 22, 2006
without further notice unless we receive relevant adverse written
comments by April 21, 2006. If we receive such comments, we will
withdraw this action before the effective date by publishing a
subsequent document that will withdraw the final action. All public
comments received will then be addressed in a subsequent final rule
based on the proposed action. The EPA will not institute a second
comment period. Any parties interested in commenting on this action
should do so at this time. If we do not receive any comments, this
action will be effective May 22, 2006.

V. Statutory and Executive Order Reviews

Executive Order 12866: Regulatory Planning and Review

    Under Executive Order 12866 (58 FR 51735, October 4, 1993), this
action is not a ``significant regulatory action'' and therefore is not
subject to review by the Office of Management and Budget.

Executive Order 13211: Actions That Significantly Affect Energy Supply,
Distribution, or Use

    Because it is not a ``significant regulatory action'' under
Executive Order 12866 or a ``significant energy action,'' this action
is also not subject to Executive Order 13211, ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001).

Regulatory Flexibility Act

    This action merely approves state law as meeting Federal
requirements and imposes no additional requirements beyond those
imposed by state law. Accordingly, the Administrator certifies that
this rule will not have a significant economic impact on a substantial
number of small entities under the Regulatory Flexibility Act (5 U.S.C.
601 et seq.).

Unfunded Mandates Reform Act

    Because this rule approves pre-existing requirements under state
law and does not impose any additional enforceable duty beyond that
required by state law, it does not contain any unfunded mandate or
significantly or uniquely affect small governments, as described in the
Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4).

Executive Order 13175: Consultation and Coordination With Indian Tribal
Governments

    This rule also does not have tribal implications because it will
not have a substantial direct effect on one or more Indian tribes, on
the relationship between the Federal Government and Indian tribes, or
on the distribution of power and responsibilities between the Federal
Government and Indian tribes, as specified by Executive Order 13175 (59
FR 22951, November 9, 2000).

Executive Order 13132: Federalism

    This action also does not have Federalism implications because it
does not have substantial direct effects on the states, on the
relationship between the national government and the states, or on the
distribution of power and responsibilities among the various levels of
government, as specified in Executive Order 13132 (64 FR 43255, August
10, 1999). This action merely approves a state rule implementing a
federal standard, and does not alter the relationship or the
distribution of power and responsibilities established in the Clean Air
Act.

Executive Order 13045: Protection of Children From Environmental Health
and Safety Risks

    This rule also is not subject to Executive Order 13045 ``Protection
of Children from Environmental Health Risks and Safety Risks'' (62 FR
19885, April 23, 1997), because it is not economically significant.

National Technology Transfer Advancement Act

    In reviewing SIP submissions, EPA's role is to approve state
choices, provided that they meet the criteria of the Clean Air Act. In
this context, in the absence of a prior existing requirement for the
state to use voluntary consensus standards (VCS), EPA has no authority
to disapprove a SIP submission for failure to use VCS. It would thus be
inconsistent with applicable law for EPA, when it reviews a SIP
submission, to use VCS in place of a SIP submission that otherwise
satisfies the provisions of the Clean Air Act. Thus, the requirements
of section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (15 U.S.C. 272 note) do not apply.

Paperwork Reduction Act

    This rule does not impose an information collection burden under
the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501
et seq.).

Congressional Review Act

    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the
Small Business Regulatory Enforcement Fairness Act of 1996, generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report, which includes a copy of the rule,
to each House of the Congress and to the Comptroller General of the
United States. EPA will submit a report containing this rule and other

required information to the U.S. Senate, the U.S. House of
Representatives, and the Comptroller General of the United States prior
to publication of the rule in the Federal Register. A major rule cannot
take effect until 60 days after it is published in the Federal
Register. This action is not a ``major rule'' as defined by 5 U.S.C.
section 804(2).
    Under section 307(b)(1) of the Clean Air Act, petitions for
judicial review of this action must be filed in the United States Court
of Appeals for the appropriate circuit by May 22, 2006. Filing a
petition for reconsideration by the Administrator of this final rule
does not affect the finality of this rule for the purposes of judicial
review nor does it extend the time within which a petition for judicial
review may be filed, and shall not postpone the effectiveness of such
rule or action. This action may not be challenged later in proceedings
to enforce its requirements. (See section 307(b)(2).)

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Incorporation by
reference, Particulate matter, Reporting and recordkeeping
requirements.

    Dated: February 17, 2006.
Norman Niedergang,
Acting Regional Administrator, Region 5.

0
For the reasons stated in the preamble, part 52, chapter I, of title 40
of the Code of Federal Regulations is amended as follows:

PART 52--[AMENDED]

0
1. The authority citation for part 52 continues to read as follows:

    Authority: 42 U.S.C. 7401 et seq.

Subpart P--Indiana

0
2. Section 52.770 is amended by adding paragraph (c)(173) to read as
follows:

Sec.  52.770  Identification of plan.

* * * * *
    (c) * * *
    (173) The Indiana Department of Environmental Management submitted
amendments to Indiana's State Implementation Plan on September 1, 2005.
The amendments include the repeal of 326 IAC 6-1, which is replaced
with new articles 326 IAC 6.5, ``Particulate Matter Limitations for all
Counties Except Lake County'' and 326 IAC 6.8, ``Particulate Matter
Limitations for Lake County.''
    (i) Incorporation by reference. The following sections of the
Indiana Administrative Code are incorporated by reference.
    (A) Amendments to Indiana Administrative Code Title 326: Air
Pollution Control Board, Article 6.5 Particulate Matter Limitations
Except Lake County, and Article 6.8 Particulate Matter Limitations For
Lake County. Adopted by the Indiana Air Pollution Control Board on May
4, 2005. Filed with the Secretary of State on August 10, 2005 and
effective on September 9, 2005. Published at Indiana Register, Volume
28, Number 12, September 1, 2005 (3454).

[FR Doc. 06-2694 Filed 3-21-06; 8:45 am]

BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 103 (Wednesday, May 29, 2013)]
[Notices]
[Pages 32244-32245]
[FR Doc No: 2013-12647]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2013-0001; FRL-9387-6]

SFIREG Full Committee; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Association of American Pesticide Control Officials
(AAPCO)/State FIFRA Issues Research and Evaluation Group (SFIREG), Full
Committee will hold a 2-day meeting, beginning on June 10, 2013 and
ending June 11, 2013. This notice announces the location and times for
the meeting and sets forth the tentative agenda topics.

DATES: The meeting will be held on Monday, June 10, 2013, from 8:30
a.m. to 5 p.m. and 8:30 a.m. to noon on Tuesday, June 11, 2013.
    To request accommodation of a disability, please contact the person
listed under FOR FURTHER INFORMATON CONTACT, preferably at least 10
days

prior to the meeting, to give EPA as much time as possible to process
your request.

ADDRESSES: The meeting will be held at EPA, One Potomac Yard (South
Bldg.), 1st Floor South Conference Room, 2777 Crystal Dr., Arlington,
VA.

FOR FURTHER INFORMATION CONTACT: Ron Kendall, Field External Affairs
Division, Office of Pesticide Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001;
telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>; email
address<EMAIL_ADDRESS>or Grier Stayton, SFIREG Executive
Secretary, P.O. Box 466, Milford, DE 19963; telephone number (302) 422-
8152; fax:<PHONE_NUMBER>; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are
interested in pesticide regulation issues affecting States and any
discussion between EPA and SFIREG on FIFRA field implementation issues
related to human health, environmental exposure to pesticides, and
insight into EPA's decision-making process. You are invited and
encouraged to attend the meetings and participate as appropriate.
Potentially affected entities may include, but are not limited to:
    Those persons who are or may be required to conduct testing of
chemical substances under the Federal Food, Drug, and Cosmetics Act
(FFDCA), or the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and those who sell, distribute or use pesticides, as well as
any non-government organization.
    This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. If you have any questions regarding the applicability of this
action to a particular entity, consult the person listed under FOR
FURTHER INFORMATION CONTACT.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket ID number EPA-HQ-
OPP-2013-0001 is available at http://www.regulations.gov, or at the
Office of Pesticide Programs Regulatory Public Docket Center (EPA/DC),
EPA West Bldg., Rm. 3334, 1301 Constitution Ave. NW., Washington, DC
20460-0001. The Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Public Reading Room is<PHONE_NUMBER>, and the telephone
number for the OPP Docket is<PHONE_NUMBER>. Please review the visitor
instructions and additional information about the docket available at
http://www.epa.gov/dockets.

II. Tentative Agenda Topics

    The following are tentative agenda topics for the upcoming meeting.
    1. Pesticide re-registration update.
    2. Office of Pesticide Programs (OPP) update/progress on issue
papers/emerging issue papers.
    3. Status of pollinator protection issues policy development.
    4. Environmental Quality Issues Working Committee (EQI WC) Report.
    5. Cooperative agreement guidance/grant template.
    6. Pesticide Operations and Management Working Committee (POM WC)
Report.
    7. National Pesticide Information Center/State Lead Agency.
    8. Insecticide performance measures development.
    9. Discussion on use of risk mitigation statements on labels.
    10. Distributor label enforcement coordination/evidence collection.
    11. Program performance measures development and implementation.
    12. Tribal Pesticide Program Council (TPPC) Report.

III. How can I request to participate in this meeting?

    This meeting is open for the public to attend. You may attend the
meeting without further notification.

List of Subjects

    Environmental protection.

    Dated: May 15, 2013.
Daniel A. Helfgott,
 Acting Director, Field External Affairs Division, Office of Pesticide
Programs.
[FR Doc. 2013-12647 Filed 5-28-13; 8:45 am]
BILLING CODE 6560-50-P